HCC38
Resource Report
Resource Website
100+ mentions
|
(RRID:CVCL_1267)
|
|
|
Miscellaneous: Direct author submission of STR profile from Girard, Luc and Gazdar, Adi F., Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: Protein expression by reverse-phase protein arrays., Omics: miRNA expression profiling., Omics: Glycoproteome analysis by proteomics., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep exome analysis., Omics: CRISPR phenotypic screen., Omics: CNV analysis., Omics: Array-based CGH., Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: ICBP43 breast cancer cell line panel., Part of: JWGray breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Triple negative breast cancer (TNBC) cell line.
|
PMID:9833771 PMID:9865903 PMID:11314036 PMID:12800145 PMID:14762065 PMID:16959974 PMID:17157791 PMID:17932254 PMID:19582160 PMID:20070913 PMID:20164919 PMID:20215515 PMID:21778573 PMID:22460905 PMID:22585861 PMID:23151021 PMID:23601657 PMID:24094812 PMID:24162158 PMID:24176112 PMID:25485619 PMID:25877200 PMID:25892236 PMID:25960936 PMID:26589293 PMID:27397505 PMID:28196595 PMID:28287265 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31395879 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
Hcc38, HCC-38, HCC 38, HCC0038, Hamon Cancer Center 38 |
|
|
BTO:BTO_0005295, CLO:CLO_0003655, EFO:EFO_0001180, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-TABM-157, ATCC:CRL-2314, BioGRID_ORCS_Cell_line:871, BioSample:SAMN03471264, BioSample:SAMN10987659, cancercelllines:CVCL_1267, CCRID:1101HUM-PUMC000220, Cell_Model_Passport:SIDM00675, ChEMBL-Cells:CHEMBL3308578, ChEMBL-Targets:CHEMBL1075460, Cosmic:749717, Cosmic:904356, Cosmic:1018475, Cosmic:1047706, Cosmic:1136365, Cosmic:1235078, Cosmic:1287932, Cosmic:1430346, Cosmic:1460229, Cosmic:1518108, Cosmic:1603212, Cosmic:1935000, Cosmic:1995432, Cosmic:2009508, Cosmic:2164993, Cosmic-CLP:749717, DepMap:ACH-000276, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:749717, GEO:GSM149979, GEO:GSM149987, GEO:GSM149995, GEO:GSM185085, GEO:GSM185086, GEO:GSM217579, GEO:GSM344382, GEO:GSM344432, GEO:GSM350536, GEO:GSM378150, GEO:GSM533398, GEO:GSM533405, GEO:GSM537968, GEO:GSM783968, GEO:GSM827244, GEO:GSM847390, GEO:GSM847487, GEO:GSM844013, GEO:GSM854621, GEO:GSM854622, GEO:GSM854623, GEO:GSM854624, GEO:GSM854625, GEO:GSM887054, GEO:GSM888124, GEO:GSM1008902, GEO:GSM1053702, GEO:GSM1172967, GEO:GSM1172875, GEO:GSM1214580, GEO:GSM1215289, GEO:GSM1215291, GEO:GSM1215293, GEO:GSM1215294, GEO:GSM1215292, GEO:GSM1215290, GEO:GSM1215295, GEO:GSM1215296, GEO:GSM1374511, GEO:GSM1401651, GEO:GSM1669859, IARC_TP53:10268, IGRhCellID:HCC38, KCLB:9S0038, LiGeA:CCLE_393, LINCS_HMS:50216, LINCS_LDP:LCL-1334, PharmacoDB:HCC38_500_2019, PRIDE:PXD005295, PRIDE:PXD008222, PRIDE:PXD030304, Progenetix:CVCL_1267, PubChem_Cell_line:CVCL_1267, Wikidata:Q54881712 |
|
|
CVCL_1267 |
2025-01-31 12:15:25 |
370 |
HCC1500
Resource Report
Resource Website
10+ mentions
|
(ATCC Cat# CRL-2329, RRID:CVCL_1254)
|
|
|
Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: Protein expression by reverse-phase protein arrays., Omics: miRNA expression profiling., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep exome analysis., Omics: CNV analysis., Population: African American., Part of: TCGA-110-CL cell line panel., Part of: MD Anderson Cell Lines Project., Part of: ICBP43 breast cancer cell line panel., Part of: JWGray breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9833771 PMID:9865903 PMID:11314036 PMID:12800145 PMID:17157791 PMID:18516279 PMID:19582160 PMID:22460905 PMID:22585861 PMID:23601657 PMID:24094812 PMID:24162158 PMID:25485619 PMID:25877200 PMID:25960936 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30787054 PMID:30894373 PMID:31068700 PMID:31395879 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
HCC-1500, Hamon Cancer Center 1500 |
ATCC |
CRL-2329 |
BTO:BTO_0006441, CLO:CLO_0003639, EFO:EFO_0001172, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-TABM-157, ArrayExpress:E-TABM-244, ATCC:CRL-2329, BioSample:SAMN03471865, BioSample:SAMN10988466, cancercelllines:CVCL_1254, Cell_Model_Passport:SIDM00879, Cosmic:687476, Cosmic:904365, Cosmic:1018471, Cosmic:1047709, Cosmic:1136374, Cosmic:1287885, Cosmic:1603203, Cosmic:1935006, Cosmic:1995424, Cosmic:2165022, Cosmic:2750522, Cosmic-CLP:1303900, DepMap:ACH-000349, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1303900, GEO:GSM217574, GEO:GSM219982, GEO:GSM344376, GEO:GSM344426, GEO:GSM350538, GEO:GSM459706, GEO:GSM783971, GEO:GSM887040, GEO:GSM888110, GEO:GSM984232, GEO:GSM1008899, GEO:GSM1053690, GEO:GSM1214571, GEO:GSM1374500, GEO:GSM1669847, IARC_TP53:22812, LiGeA:CCLE_498, LINCS_HMS:50579, LINCS_LDP:LCL-1325, PharmacoDB:HCC1500_478_2019, PRIDE:PXD030304, Progenetix:CVCL_1254, SLKBase:3524, Wikidata:Q54881583 |
|
|
CVCL_1254 |
2025-01-31 12:15:22 |
14 |
HCC2998
Resource Report
Resource Website
1+ mentions
|
(RRID:CVCL_1266)
|
|
|
Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: Protein expression by reverse-phase protein arrays., Omics: Metabolome analysis., Omics: lncRNA expression profiling., Omics: Fluorescence phenotype profiling., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep quantitative phosphoproteome analysis., Omics: Deep proteome analysis., Omics: Deep exome analysis., Omics: CRISPR phenotypic screen., Omics: CNV analysis., Omics: Array-based CGH., Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: JFCR39 cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2041050 PMID:3335022 PMID:10700174 PMID:15748285 PMID:15900046 PMID:16969076 PMID:17088437 PMID:18277095 PMID:19372543 PMID:20164919 PMID:20570890 PMID:20606684 PMID:22068913 PMID:22336246 PMID:22347499 PMID:22384151 PMID:22628656 PMID:23856246 PMID:23933261 PMID:24279929 PMID:24670534 PMID:24755471 PMID:25926053 PMID:25944804 PMID:27377824 PMID:27397505 PMID:27807467 PMID:28179481 PMID:28196595 PMID:28683746 PMID:28854368 PMID:30894373 PMID:30971826 PMID:35839778
|
Cancer cell line
|
Sex unspecified |
HCC-2998, HCC.2998, HCC 2998, Hamon Cancer Center 2998 |
|
|
BTO:BTO_0003322, CLO:CLO_0009962, EFO:EFO_0005370, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:872, cancercelllines:CVCL_1266, Cell_Model_Passport:SIDM00118, ChEMBL-Cells:CHEMBL3308074, ChEMBL-Targets:CHEMBL613855, ColonAtlas:HCC2998, Cosmic:875899, Cosmic:905971, Cosmic:974245, Cosmic:1092599, Cosmic:1305352, Cosmic:1312337, Cosmic:1436017, Cosmic:1479602, Cosmic:1676741, Cosmic:1803942, Cosmic:1998441, Cosmic:2301977, Cosmic:2811049, Cosmic-CLP:905971, DepMap:ACH-001081, EGA:EGAS00001000978, GDSC:905971, GEO:GSM2146, GEO:GSM50187, GEO:GSM50251, GEO:GSM743442, GEO:GSM750796, GEO:GSM799330, GEO:GSM799393, GEO:GSM846354, GEO:GSM844550, GEO:GSM844551, GEO:GSM1153401, GEO:GSM1178115, GEO:GSM1178116, GEO:GSM1178117, GEO:GSM1181249, GEO:GSM1181265, GEO:GSM1346873, GEO:GSM1448169, GEO:GSM1669856, GEO:GSM2124654, GEO:GSM2550000, IARC_TP53:18070, IARC_TP53:21115, LINCS_LDP:LCL-1191, NCI-DTP:HCC-2998, PharmacoDB:HCC2998_497_2019, PRIDE:PXD005235, PRIDE:PXD005942, PRIDE:PXD005946, PRIDE:PXD030304, Progenetix:CVCL_1266, PubChem_Cell_line:CVCL_1266, SKY/M-FISH/CGH:2794, Wikidata:Q54881683 |
|
|
CVCL_1266 |
2025-01-31 12:15:24 |
3 |
HCC1806
Resource Report
Resource Website
500+ mentions
|
(RRID:CVCL_1258)
|
|
|
Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: Protein expression by reverse-phase protein arrays., Omics: miRNA expression profiling., Omics: Pol2 ChIP-seq epigenome analysis., Omics: H4K20me1 ChIP-seq epigenome analysis., Omics: H3K9ac ChIP-seq epigenome analysis., Omics: H3K4me3 ChIP-seq epigenome analysis., Omics: H3K4me2 ChIP-seq epigenome analysis., Omics: H3K4me1 ChIP-seq epigenome analysis., Omics: H3K27me3 ChIP-seq epigenome analysis., Omics: H3K27ac ChIP-seq epigenome analysis., Omics: H2A.Z ChIP-seq epigenome analysis., Omics: CTCF ChIP-seq epigenome analysis., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep exome analysis., Omics: CRISPR phenotypic screen., Omics: CNV analysis., Omics: Array-based CGH., Population: African American., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: ICBP43 breast cancer cell line panel., Part of: JWGray breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Triple negative breast cancer (TNBC) cell line.
|
PMID:9288768 PMID:9833771 PMID:9865903 PMID:11314036 PMID:12353263 PMID:12800145 PMID:19582160 PMID:20070913 PMID:20164919 PMID:20679594 PMID:21603256 PMID:21778573 PMID:22460905 PMID:22585861 PMID:23601657 PMID:24176112 PMID:25485619 PMID:25877200 PMID:25892236 PMID:25960936 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30787054 PMID:30835260 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
Hcc1806, HCC-1806, Hamon Cancer Center 1806 |
|
|
BTO:BTO_0006395, CLO:CLO_0003644, EFO:EFO_0005373, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-2335, BioGRID_ORCS_Cell_line:662, BioSample:SAMN03472709, BioSample:SAMN10988428, cancercelllines:CVCL_1258, Cell_Model_Passport:SIDM00875, ChEMBL-Cells:CHEMBL3308135, ChEMBL-Targets:CHEMBL1075457, CLS:300467, Cosmic:687479, Cosmic:904367, Cosmic:907047, Cosmic:1047705, Cosmic:1287888, Cosmic:1460234, Cosmic:1603206, Cosmic:1935008, Cosmic-CLP:907047, DepMap:ACH-000624, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:907047, GEO:GSM217576, GEO:GSM219878, GEO:GSM344339, GEO:GSM344389, GEO:GSM350528, GEO:GSM378147, GEO:GSM783942, GEO:GSM847325, GEO:GSM847482, GEO:GSM844547, GEO:GSM844546, GEO:GSM887044, GEO:GSM888114, GEO:GSM1053713, GEO:GSM1172960, GEO:GSM1172869, GEO:GSM1374504, GEO:GSM1374505, GEO:GSM1669850, IARC_TP53:10273, KCB:KCB 2014032YJ, LiGeA:CCLE_250, LINCS_HMS:50211, LINCS_LDP:LCL-1960, PharmacoDB:HCC1806_483_2019, PRIDE:PXD008222, PRIDE:PXD030304, Progenetix:CVCL_1258, PubChem_Cell_line:CVCL_1258, SLKBase:3534, Ubigene:YC-C073, Wikidata:Q54881605 |
|
|
CVCL_1258 |
2025-01-31 12:15:22 |
551 |
HCC366
Resource Report
Resource Website
1+ mentions
|
(RRID:CVCL_2059)
|
|
|
Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: Protein expression by reverse-phase protein arrays., Omics: miRNA expression profiling., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep exome analysis., Omics: Array-based CGH., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9559342 PMID:10987304 PMID:11314036 PMID:16187286 PMID:18083107 PMID:19472407 PMID:20215515 PMID:20557307 PMID:20624269 PMID:20679594 PMID:22460905 PMID:22961666 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:27602502 PMID:28196595 PMID:29681454 PMID:30038707 PMID:30894373 PMID:31068700 PMID:31803961 PMID:35839778
|
Cancer cell line
|
Female |
HCC-366, HCC0366, Hamon Cancer Center 366 |
|
|
CLO:CLO_0037011, EFO:EFO_0003131, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473079, BioSample:SAMN10988035, cancercelllines:CVCL_2059, Cell_Model_Passport:SIDM01070, CLS:302155, Cosmic:877261, Cosmic:903631, Cosmic:1146935, Cosmic:1239916, Cosmic:1518096, Cosmic:2125184, Cosmic:2559771, Cosmic-CLP:1240144, DepMap:ACH-000840, DSMZ:ACC-492, DSMZCellDive:ACC-492, EGA:EGAS00001000610, EGA:EGAS00001000978, GEO:GSM62335, GEO:GSM108871, GEO:GSM108872, GEO:GSM253363, GEO:GSM434261, GEO:GSM784223, GEO:GSM794379, GEO:GSM827365, GEO:GSM887053, GEO:GSM888123, GEO:GSM1669858, GEO:GSM2807229, GEO:GSM2807230, IARC_TP53:28330, IGRhCellID:HCC366_02GEO, KCLB:70366, KCLB:70966, LiGeA:CCLE_150, LINCS_LDP:LCL-1605, PharmacoDB:HCC366_458_2019, PRIDE:PXD030304, Progenetix:CVCL_2059, Wikidata:Q54881708 |
|
|
CVCL_2059 |
2025-01-31 12:15:25 |
3 |
HCC1954
Resource Report
Resource Website
500+ mentions
|
(RRID:CVCL_1259)
|
|
|
Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: shRNA library screening., Omics: Protein expression by reverse-phase protein arrays., Omics: miRNA expression profiling., Omics: Hi-C chromosome conformation analysis., Omics: Glycoproteome analysis by proteomics., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep exome analysis., Omics: CRISPR phenotypic screen., Omics: CNV analysis., Omics: H4K8ac ChIP-seq epigenome analysis., Omics: H3K9me3 ChIP-seq epigenome analysis., Omics: H3K9ac ChIP-seq epigenome analysis., Omics: H3K79me2 ChIP-seq epigenome analysis., Omics: H3K4me3 ChIP-seq epigenome analysis., Omics: H3K4me1 ChIP-seq epigenome analysis., Omics: H3K36me3 ChIP-seq epigenome analysis., Omics: H3K27me3 ChIP-seq epigenome analysis., Omics: H3K27ac ChIP-seq epigenome analysis., Omics: H3K23ac ChIP-seq epigenome analysis., Omics: H2BK120ub ChIP-seq epigenome analysis., Omics: Array-based CGH., Population: East Indian., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: ICBP43 breast cancer cell line panel., Part of: JWGray breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9833771 PMID:11314036 PMID:16959974 PMID:17157791 PMID:17932254 PMID:19582160 PMID:20070913 PMID:20164919 PMID:20215515 PMID:21378333 PMID:22460905 PMID:22585861 PMID:23151021 PMID:23601657 PMID:23637631 PMID:24094812 PMID:24162158 PMID:24176112 PMID:25485619 PMID:25877200 PMID:25960936 PMID:25984343 PMID:26589293 PMID:27397505 PMID:28196595 PMID:28287265 PMID:28889351 PMID:29273624 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
HCC-1954, Hamon Cancer Center 1954 |
|
|
BTO:BTO_0005368, CLO:CLO_0003647, EFO:EFO_0001175, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-TABM-157, ATCC:CRL-2338, BCRJ:0280, BioGRID_ORCS_Cell_line:425, BioSample:SAMN03473018, BioSample:SAMN10987850, cancercelllines:CVCL_1259, Cell_Model_Passport:SIDM00872, ChEMBL-Cells:CHEMBL3308107, ChEMBL-Targets:CHEMBL1075459, Cosmic:749709, Cosmic:904369, Cosmic:1136367, Cosmic:1235077, Cosmic:1287889, Cosmic:1308993, Cosmic:1430345, Cosmic:1473150, Cosmic:1518107, Cosmic:1603208, Cosmic:1717243, Cosmic:1935009, Cosmic:1995428, Cosmic:2165007, Cosmic-CLP:749709, DepMap:ACH-000859, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:749709, GEO:GSM185081, GEO:GSM185082, GEO:GSM186724, GEO:GSM217578, GEO:GSM219962, GEO:GSM274675, GEO:GSM303673, GEO:GSM303675, GEO:GSM303680, GEO:GSM303682, GEO:GSM303684, GEO:GSM303687, GEO:GSM303689, GEO:GSM303691, GEO:GSM303695, GEO:GSM303698, GEO:GSM303700, GEO:GSM303704, GEO:GSM303707, GEO:GSM303709, GEO:GSM303712, GEO:GSM303715, GEO:GSM303719, GEO:GSM303721, GEO:GSM303723, GEO:GSM303726, GEO:GSM303729, GEO:GSM303731, GEO:GSM303735, GEO:GSM303738, GEO:GSM303740, GEO:GSM303742, GEO:GSM303745, GEO:GSM303747, GEO:GSM303750, GEO:GSM303753, GEO:GSM303754, GEO:GSM303760, GEO:GSM303762, GEO:GSM303766, GEO:GSM303769, GEO:GSM303770, GEO:GSM303775, GEO:GSM303777, GEO:GSM303780, GEO:GSM303784, GEO:GSM303786, GEO:GSM303789, GEO:GSM337683, GEO:GSM337684, GEO:GSM337685, GEO:GSM337686, GEO:GSM337687, GEO:GSM337688, GEO:GSM337689, GEO:GSM337690, GEO:GSM337691, GEO:GSM337692, GEO:GSM337693, GEO:GSM337694, GEO:GSM337695, GEO:GSM344374, GEO:GSM344424, GEO:GSM350499, GEO:GSM481299, GEO:GSM718290, GEO:GSM783937, GEO:GSM847341, GEO:GSM847483, GEO:GSM887046, GEO:GSM888116, GEO:GSM1008901, GEO:GSM1053712, GEO:GSM1172962, GEO:GSM1172871, GEO:GSM1215272, GEO:GSM1374508, GEO:GSM1374509, GEO:GSM1401665, GEO:GSM1669852, GEO:GSM2258830, GEO:GSM2258831, GEO:GSM2258832, GEO:GSM2258833, GEO:GSM2258834, GEO:GSM2258835, GEO:GSM2258836, GEO:GSM2258837, GEO:GSM2258838, GEO:GSM2258839, GEO:GSM2258840, GEO:GSM2258841, GEO:GSM2258842, GEO:GSM2258843, GEO:GSM2258844, GEO:GSM2258845, GEO:GSM2258846, GEO:GSM2258847, GEO:GSM2258929, GEO:GSM2258930, GEO:GSM2258931, GEO:GSM3258551, IARC_TP53:21363, IGRhCellID:HCC1954, KCLB:9S1954, LiGeA:CCLE_705, LINCS_HMS:50213, LINCS_LDP:LCL-1332, Lonza:1357, PharmacoDB:HCC1954_486_2019, PRIDE:PXD002486, PRIDE:PXD005339, PRIDE:PXD030304, Progenetix:CVCL_1259, PubChem_Cell_line:CVCL_1259, SLKBase:3543, Wikidata:Q54881618 |
|
|
CVCL_1259 |
2025-01-31 12:15:23 |
569 |
HCC1500
Resource Report
Resource Website
10+ mentions
|
(RRID:CVCL_1254)
|
|
|
Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: Protein expression by reverse-phase protein arrays., Omics: miRNA expression profiling., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep exome analysis., Omics: CNV analysis., Population: African American., Part of: TCGA-110-CL cell line panel., Part of: MD Anderson Cell Lines Project., Part of: ICBP43 breast cancer cell line panel., Part of: JWGray breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9833771 PMID:9865903 PMID:11314036 PMID:12800145 PMID:17157791 PMID:18516279 PMID:19582160 PMID:22460905 PMID:22585861 PMID:23601657 PMID:24094812 PMID:24162158 PMID:25485619 PMID:25877200 PMID:25960936 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30787054 PMID:30894373 PMID:31068700 PMID:31395879 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
HCC-1500, Hamon Cancer Center 1500 |
|
|
BTO:BTO_0006441, CLO:CLO_0003639, EFO:EFO_0001172, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-TABM-157, ArrayExpress:E-TABM-244, ATCC:CRL-2329, BioSample:SAMN03471865, BioSample:SAMN10988466, cancercelllines:CVCL_1254, Cell_Model_Passport:SIDM00879, Cosmic:687476, Cosmic:904365, Cosmic:1018471, Cosmic:1047709, Cosmic:1136374, Cosmic:1287885, Cosmic:1603203, Cosmic:1935006, Cosmic:1995424, Cosmic:2165022, Cosmic:2750522, Cosmic-CLP:1303900, DepMap:ACH-000349, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1303900, GEO:GSM217574, GEO:GSM219982, GEO:GSM344376, GEO:GSM344426, GEO:GSM350538, GEO:GSM459706, GEO:GSM783971, GEO:GSM887040, GEO:GSM888110, GEO:GSM984232, GEO:GSM1008899, GEO:GSM1053690, GEO:GSM1214571, GEO:GSM1374500, GEO:GSM1669847, IARC_TP53:22812, LiGeA:CCLE_498, LINCS_HMS:50579, LINCS_LDP:LCL-1325, PharmacoDB:HCC1500_478_2019, PRIDE:PXD030304, Progenetix:CVCL_1254, SLKBase:3524, Wikidata:Q54881583 |
|
|
CVCL_1254 |
2025-01-31 12:15:22 |
14 |
HCC15
Resource Report
Resource Website
10+ mentions
|
(RRID:CVCL_2057)
|
|
|
Miscellaneous: Direct author submission of STR profile from Girard, Luc and Gazdar, Adi F., Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: Protein expression by reverse-phase protein arrays., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep exome analysis., Omics: CRISPR phenotypic screen., Omics: Array-based CGH., Population: African American., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9559342 PMID:10987304 PMID:11314036 PMID:11464291 PMID:16187286 PMID:18083107 PMID:19472407 PMID:20215515 PMID:20557307 PMID:20679594 PMID:22460905 PMID:22961666 PMID:23381221 PMID:24002593 PMID:25120651 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28196595 PMID:29681454 PMID:30038707 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31803961 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Male |
HCC-15, HCC0015, Hamon Cancer Center 15 |
|
|
CLO:CLO_0009999, EFO:EFO_0003129, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:663, BioSample:SAMN03473175, BioSample:SAMN10987789, cancercelllines:CVCL_2057, Cell_Model_Passport:SIDM01072, Cosmic:877105, Cosmic:903625, Cosmic:1146927, Cosmic:1219058, Cosmic:1239908, Cosmic:1518094, Cosmic:1802314, Cosmic:1925846, Cosmic:2060531, Cosmic:2125188, Cosmic-CLP:1240143, DepMap:ACH-000878, DSMZ:ACC-496, DSMZCellDive:ACC-496, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1240143, GEO:GSM62968, GEO:GSM108863, GEO:GSM108864, GEO:GSM253336, GEO:GSM434318, GEO:GSM784212, GEO:GSM784277, GEO:GSM794372, GEO:GSM827364, GEO:GSM887043, GEO:GSM888113, GEO:GSM1374499, GEO:GSM1669846, IARC_TP53:28297, IGRhCellID:HCC15GEO, KCLB:70015, LiGeA:CCLE_031, LINCS_LDP:LCL-1604, PharmacoDB:HCC15_450_2019, PRIDE:PXD030304, Progenetix:CVCL_2057, Wikidata:Q54881579 |
|
|
CVCL_2057 |
2025-01-31 12:15:22 |
10 |
HCC1937
Resource Report
Resource Website
1000+ mentions
|
(RRID:CVCL_0290)
|
|
|
Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: Protein expression by reverse-phase protein arrays., Omics: miRNA expression profiling., Omics: Metabolome analysis., Omics: HLA class I peptidome analysis by proteomics., Omics: H4K8ac ChIP-seq epigenome analysis., Omics: H3K9me3 ChIP-seq epigenome analysis., Omics: H3K9ac ChIP-seq epigenome analysis., Omics: H3K79me2 ChIP-seq epigenome analysis., Omics: H3K4me3 ChIP-seq epigenome analysis., Omics: H3K4me1 ChIP-seq epigenome analysis., Omics: H3K36me3 ChIP-seq epigenome analysis., Omics: H3K27me3 ChIP-seq epigenome analysis., Omics: H3K27ac ChIP-seq epigenome analysis., Omics: H3K23ac ChIP-seq epigenome analysis., Omics: H2BK120ub ChIP-seq epigenome analysis., Omics: Glycoproteome analysis by proteomics., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep proteome analysis., Omics: Deep exome analysis., Omics: CRISPR phenotypic screen., Omics: CNV analysis., Omics: Array-based CGH., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: ICBP43 breast cancer cell line panel., Part of: JWGray breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Triple negative breast cancer (TNBC) cell line.
|
PMID:9699648 PMID:9833771 PMID:9865903 PMID:10635334 PMID:11314036 PMID:12353263 PMID:12419185 PMID:12800145 PMID:14762065 PMID:15162061 PMID:16397213 PMID:16541312 PMID:16959974 PMID:17157791 PMID:17334996 PMID:17932254 PMID:19582160 PMID:19593635 PMID:20070913 PMID:20215515 PMID:21778573 PMID:22032724 PMID:22414580 PMID:22460905 PMID:22585861 PMID:23151021 PMID:23601657 PMID:24094812 PMID:24162158 PMID:24176112 PMID:25485619 PMID:25576301 PMID:25877200 PMID:25892236 PMID:25960936 PMID:26589293 PMID:27397505 PMID:28196595 PMID:28287265 PMID:28889351 PMID:29273624 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:34339474 PMID:35839778
|
Cancer cell line
|
Female |
HCC-1937, HCC/1937, Hamon Cancer Center 1937 |
|
|
BTO:BTO_0003323, CLO:CLO_0003645, EFO:EFO_0001174, MCCL:MCC:0000180, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-TABM-157, ATCC:CRL-2336, BCRJ:0387, BioGRID_ORCS_Cell_line:427, BioSample:SAMN01821555, BioSample:SAMN01821629, BioSample:SAMN03473202, BioSample:SAMN05292445, BioSample:SAMN10987920, cancercelllines:CVCL_0290, CCRID:1101HUM-PUMC000471, CCRID:3101HUMTCHu148, Cell_Model_Passport:SIDM00874, ChEMBL-Cells:CHEMBL3308371, ChEMBL-Targets:CHEMBL1075458, CLS:305064, Cosmic:749714, Cosmic:904368, Cosmic:1007153, Cosmic:1046927, Cosmic:1047704, Cosmic:1176626, Cosmic:1235083, Cosmic:1287892, Cosmic:1289389, Cosmic:1309007, Cosmic:1430351, Cosmic:1460235, Cosmic:1472999, Cosmic:1518113, Cosmic:1603207, Cosmic:1995427, Cosmic:2009511, Cosmic:2164992, Cosmic-CLP:749714, DepMap:ACH-000223, DSMZ:ACC-513, DSMZCellDive:ACC-513, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:749714, GEO:GSM155209, GEO:GSM185079, GEO:GSM185080, GEO:GSM186723, GEO:GSM217577, GEO:GSM219873, GEO:GSM274654, GEO:GSM344367, GEO:GSM344417, GEO:GSM350544, GEO:GSM378151, GEO:GSM421867, GEO:GSM459723, GEO:GSM481301, GEO:GSM533403, GEO:GSM533410, GEO:GSM537973, GEO:GSM783936, GEO:GSM783943, GEO:GSM847340, GEO:GSM887045, GEO:GSM888115, GEO:GSM1008900, GEO:GSM1053709, GEO:GSM1172961, GEO:GSM1172870, GEO:GSM1214588, GEO:GSM1238126, GEO:GSM1374506, GEO:GSM1374507, GEO:GSM1401668, GEO:GSM1669851, GEO:GSM2258902, GEO:GSM2258903, GEO:GSM2258904, GEO:GSM2258905, GEO:GSM2258906, GEO:GSM2258907, GEO:GSM2258908, GEO:GSM2258909, GEO:GSM2258910, GEO:GSM2258911, GEO:GSM2258912, GEO:GSM2258913, GEO:GSM2258914, GEO:GSM2258915, GEO:GSM2258916, GEO:GSM2258917, GEO:GSM2258918, GEO:GSM2258919, GEO:GSM2258926, GEO:GSM2258927, GEO:GSM2258928, IARC_TP53:10102, IARC_TP53:10274, IGRhCellID:HCC1937, KCB:KCB 200944YJ, KCLB:9S1937, LiGeA:CCLE_424, LINCS_HMS:50212, LINCS_LDP:LCL-1331, Lonza:905, MetaboLights:MTBLS337, PharmacoDB:HCC1937_485_2019, PRIDE:PXD000309, PRIDE:PXD000394, PRIDE:PXD005295, PRIDE:PXD008222, PRIDE:PXD030304, Progenetix:CVCL_0290, PubChem_Cell_line:CVCL_0290, SLKBase:3539, TOKU-E:1402, Wikidata:Q28872477 |
|
|
CVCL_0290 |
2025-01-31 12:15:23 |
1062 |
HCE-4
Resource Report
Resource Website
|
(RRID:CVCL_1271)
|
|
|
Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep exome analysis., Omics: CRISPR phenotypic screen., Population: African American., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2263646 PMID:2302677 PMID:2415247 PMID:2420787 PMID:7972006 PMID:20164919 PMID:27397505 PMID:30894373 PMID:30971826 PMID:35839778
|
Cancer cell line
|
Female |
HCE4 |
|
|
BTO:BTO_0005572, CLO:CLO_0009932, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:869, cancercelllines:CVCL_1271, Cell_Model_Passport:SIDM00052, ChEMBL-Cells:CHEMBL3308199, ChEMBL-Targets:CHEMBL2366207, Cosmic:753559, Cosmic:923186, Cosmic:934539, Cosmic:1394519, Cosmic-CLP:753559, DepMap:ACH-002243, EGA:EGAS00001000978, GDSC:753559, GEO:GSM482501, GEO:GSM1669865, IARC_TP53:258, LINCS_LDP:LCL-1563, PharmacoDB:HCE4_514_2019, PRIDE:PXD030304, Progenetix:CVCL_1271, PubChem_Cell_line:CVCL_1271, Wikidata:Q54881849 |
|
|
CVCL_1271 |
2025-01-31 12:15:28 |
0 |
HCC827
Resource Report
Resource Website
1000+ mentions
|
(RRID:CVCL_2063)
|
|
|
Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: shRNA library screening., Omics: Protein expression by reverse-phase protein arrays., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep proteome analysis., Omics: Deep exome analysis., Omics: Array-based CGH., Karyotypic information: Flat-moded hypotriploid karyotype with 6% polyploidy (DSMZ=ACC-566)., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9559342 PMID:10987304 PMID:11314036 PMID:16187286 PMID:18083107 PMID:20215515 PMID:20679594 PMID:22460905 PMID:22751098 PMID:22961666 PMID:23733853 PMID:25485619 PMID:25877200 PMID:25960936 PMID:25984343 PMID:26361996 PMID:26589293 PMID:27397505 PMID:28196595 PMID:29444439 PMID:29681454 PMID:30038707 PMID:30894373 PMID:31068700 PMID:31803961 PMID:31978347 PMID:35117401 PMID:35839778 PMID:39061985
|
Cancer cell line
|
Female |
HCC-827, HCC 827, HCC0827, Hamon Cancer Center 827 |
|
|
BTO:BTO_0004082, CLO:CLO_0003659, CLO:CLO_0037015, EFO:EFO_0003137, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-2868, BCRJ:0351, BioGRID_ORCS_Cell_line:424, BioSample:SAMN03472697, BioSample:SAMN10988440, cancercelllines:CVCL_2063, CCRID:1101HUM-PUMC000478, CCRID:3101HUMSCSP538, CCRID:3101HUMTCHu153, Cell_Model_Passport:SIDM01067, ChEMBL-Cells:CHEMBL4295384, ChEMBL-Targets:CHEMBL4296422, CLS:305041, Cosmic:903634, Cosmic:1028936, Cosmic:1128251, Cosmic:1146941, Cosmic:1219071, Cosmic:1352407, Cosmic:1802300, Cosmic:1995436, Cosmic:2125263, Cosmic-CLP:1240146, DepMap:ACH-000012, DSMZ:ACC-566, DSMZCellDive:ACC-566, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1240146, GEO:GSM63350, GEO:GSM108883, GEO:GSM108884, GEO:GSM183436, GEO:GSM183437, GEO:GSM253425, GEO:GSM434274, GEO:GSM466319, GEO:GSM513969, GEO:GSM514323, GEO:GSM784276, GEO:GSM794382, GEO:GSM827206, GEO:GSM844553, GEO:GSM887060, GEO:GSM888130, GEO:GSM935083, GEO:GSM938752, GEO:GSM938753, GEO:GSM938754, GEO:GSM938755, GEO:GSM938756, GEO:GSM938757, GEO:GSM1557132, GEO:GSM1669864, IARC_TP53:28333, IGRhCellID:HCC827GEO, KCLB:70827, LiGeA:CCLE_221, LINCS_LDP:LCL-1608, PharmacoDB:HCC827_512_2019, PRIDE:PXD002556, PRIDE:PXD030304, Progenetix:CVCL_2063, PubChem_Cell_line:CVCL_2063, Ubigene:YC-C043, Wikidata:Q54881781 |
|
|
CVCL_2063 |
2025-01-31 12:15:26 |
1270 |
HCT 15
Resource Report
Resource Website
500+ mentions
Discontinued
|
(RRID:CVCL_0292)
|
|
|
Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: Protein expression by reverse-phase protein arrays., Omics: N-glycan profiling., Omics: miRNA expression profiling., Omics: Metabolome analysis., Omics: lncRNA expression profiling., Omics: Fluorescence phenotype profiling., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep quantitative phosphoproteome analysis., Omics: Deep proteome analysis., Omics: Deep exome analysis., Omics: CRISPR phenotypic screen., Omics: CNV analysis., Omics: Array-based CGH., Population: Caucasian., Part of: RAS genetic alteration cell panel (ATCC TCP-1031)., Part of: PI3K genetic alteration cell panel (ATCC TCP-1028)., Part of: NCI-60 cancer cell line panel., Part of: NCI RAS program mutant KRAS cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: JFCR39 cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:427742 PMID:2041050 PMID:7139607 PMID:7247963 PMID:7621404 PMID:7972006 PMID:8197130 PMID:8464898 PMID:9000147 PMID:9000572 PMID:9809040 PMID:10700174 PMID:10737795 PMID:11314036 PMID:11414198 PMID:11416159 PMID:11526487 PMID:11668190 PMID:12584437 PMID:15748285 PMID:15900046 PMID:16854228 PMID:17088437 PMID:18167186 PMID:19372543 PMID:20164919 PMID:20215515 PMID:20570890 PMID:20606684 PMID:22068913 PMID:22336246 PMID:22347499 PMID:22384151 PMID:22460905 PMID:22628656 PMID:23856246 PMID:23933261 PMID:24042735 PMID:24279929 PMID:24670534 PMID:24755471 PMID:25485619 PMID:25877200 PMID:25926053 PMID:25944804 PMID:26169745 PMID:26537799 PMID:26589293 PMID:27377824 PMID:27397505 PMID:27807467 PMID:28179481 PMID:28192450 PMID:28196595 PMID:28683746 PMID:28854368 PMID:29444439 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Male |
HCT-15, HCT.15, HCT15 |
|
|
BTO:BTO_0002201, CLO:CLO_0003666, EFO:EFO_0002188, MCCL:MCC:0000182, CLDB:cl1576, CLDB:cl4985, AddexBio:C0009010/381, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CCL-225, BCRC:60539, BioGRID_ORCS_Cell_line:868, BioSample:SAMN01821556, BioSample:SAMN01821630, BioSample:SAMN03471553, BioSample:SAMN10987770, cancercelllines:CVCL_0292, CCRID:1101HUM-PUMC000247, CCRID:3101HUMTCHu133, CCRID:4201HUM-CCTCC00250, CCTCC:GDC0250, Cell_Model_Passport:SIDM00789, ChEMBL-Cells:CHEMBL3307945, ChEMBL-Targets:CHEMBL612263, CLS:300229, ColonAtlas:HCT15, Cosmic:711261, Cosmic:873700, Cosmic:875902, Cosmic:887222, Cosmic:897458, Cosmic:905007, Cosmic:905937, Cosmic:913889, Cosmic:934567, Cosmic:947354, Cosmic:995403, Cosmic:1044258, Cosmic:1057756, Cosmic:1066206, Cosmic:1092601, Cosmic:1122324, Cosmic:1132569, Cosmic:1175841, Cosmic:1184092, Cosmic:1187307, Cosmic:1218878, Cosmic:1305354, Cosmic:1310950, Cosmic:1312338, Cosmic:1436020, Cosmic:1466814, Cosmic:1479592, Cosmic:1526922, Cosmic:1609492, Cosmic:1676747, Cosmic:1708403, Cosmic:1995438, Cosmic:1998443, Cosmic:2036655, Cosmic:2156942, Cosmic:2301979, Cosmic:2664053, Cosmic:2727470, Cosmic:2760066, Cosmic:2800585, Cosmic:2811051, Cosmic-CLP:905937, DepMap:ACH-000997, DSMZ:ACC-357, DSMZCellDive:ACC-357, ECACC:91030712, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:905937, GEO:GSM2129, GEO:GSM50189, GEO:GSM50253, GEO:GSM206502, GEO:GSM274763, GEO:GSM274764, GEO:GSM481406, GEO:GSM513816, GEO:GSM514293, GEO:GSM741257, GEO:GSM743444, GEO:GSM750792, GEO:GSM784011, GEO:GSM799332, GEO:GSM799395, GEO:GSM846356, GEO:GSM844554, GEO:GSM887063, GEO:GSM888133, GEO:GSM1153402, GEO:GSM1178151, GEO:GSM1178152, GEO:GSM1178153, GEO:GSM1181251, GEO:GSM1181363, GEO:GSM1346875, GEO:GSM1374519, GEO:GSM1374520, GEO:GSM1374521, GEO:GSM1374522, GEO:GSM1448178, GEO:GSM1669869, GEO:GSM2124665, GEO:GSM2550002, IARC_TP53:21114, ICLC:HTL00001, IGRhCellID:HCT15, KCB:KCB 2011097YJ, KCLB:10225, LiGeA:CCLE_761, LINCS_LDP:LCL-1178, Lonza:492, MetaboLights:MTBLS227, NCI-DTP:HCT-15, PharmacoDB:HCT15_518_2019, PRIDE:PXD005235, PRIDE:PXD005942, PRIDE:PXD005946, PRIDE:PXD030304, Progenetix:CVCL_0292, PubChem_Cell_line:CVCL_0292, RCB:RCB1958, SKY/M-FISH/CGH:2786, TKG:TKG 0504, TOKU-E:1423, Wikidata:Q54882006 |
|
|
CVCL_0292 |
2025-01-31 12:15:32 |
906 |
HCT 116
Resource Report
Resource Website
10000+ mentions
|
(RRID:CVCL_0291)
|
|
|
Omics: Transcriptome analysis by serial analysis of gene expression (SAGE)., Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: Transcriptome analysis by massively parallel signature sequencing (MPSS)., Omics: SNP array analysis., Omics: shRNA library screening., Omics: Protein expression by reverse-phase protein arrays., Omics: N-glycan profiling., Omics: miRNA expression profiling., Omics: Metabolome analysis., Omics: lncRNA expression profiling., Omics: HLA class I peptidome analysis by proteomics., Omics: Fluorescence phenotype profiling., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep quantitative phosphoproteome analysis., Omics: Deep proteome analysis., Omics: Deep phosphoproteome analysis., Omics: Extracellular vesicles proteome analysis., Omics: Deep exome analysis., Omics: CRISPR phenotypic screen., Omics: CNV analysis., Omics: H3K4me3 ChIP-seq epigenome analysis., Omics: CTCF ChIP-seq epigenome analysis., Omics: Array-based CGH., Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: NCI RAS program mutant KRAS cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: JFCR39 cancer cell line panel., Part of: FGFR genetic alteration cell panel (ATCC TCP-1034)., Part of: ENCODE project common cell types; tier 3., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: AstraZeneca Colorectal cell line (AZCL) panel.
|
PMID:2041050 PMID:2835152 PMID:3335022 PMID:3955419 PMID:6437669 PMID:7214343 PMID:7761852 PMID:7824277 PMID:7972006 PMID:9000147 PMID:9000572 PMID:9023415 PMID:9178645 PMID:9294210 PMID:9515795 PMID:9715273 PMID:10612807 PMID:10674020 PMID:10700174 PMID:10700188 PMID:10737795 PMID:11226274 PMID:11314036 PMID:11414198 PMID:11416159 PMID:11526487 PMID:11687795 PMID:12068308 PMID:12584437 PMID:12615714 PMID:12671075 PMID:12714694 PMID:15748285 PMID:15900046 PMID:16418264 PMID:16854228 PMID:17088437 PMID:17178751 PMID:17363507 PMID:18258742 PMID:18340113 PMID:19372543 PMID:19927377 PMID:20164919 PMID:20215515 PMID:20570890 PMID:20606684 PMID:21912889 PMID:22068913 PMID:22336246 PMID:22347499 PMID:22384151 PMID:22460905 PMID:22628656 PMID:23272949 PMID:23546019 PMID:23631600 PMID:23649806 PMID:23671654 PMID:23856246 PMID:23933261 PMID:24042735 PMID:24279929 PMID:24670534 PMID:24755471 PMID:25485619 PMID:25576301 PMID:25841592 PMID:25877200 PMID:25926053 PMID:25944804 PMID:25960936 PMID:25984343 PMID:26169745 PMID:26589293 PMID:26537799 PMID:26719794 PMID:27377824 PMID:27397505 PMID:27807467 PMID:28179481 PMID:28192450 PMID:28196595 PMID:28601559 PMID:28683746 PMID:28854368 PMID:29101300 PMID:29207035 PMID:29444439 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:32172478 PMID:32927768 PMID:34320349 PMID:35839778 PMID:36648961
|
Cancer cell line
|
Male |
HCT-116, HCT.116, HCT_116, HCT116, HCT116wt, CoCL2 |
|
|
BTO:BTO_0001109, CLO:CLO_0003665, EFO:EFO_0002824, MCCL:MCC:0000181, CLDB:cl1574, CLDB:cl1575, CLDB:cl5198, 4DN:4DNSRMYUIVGD, Abcam:ab255451, Abcam:ab273730, Abcam:ab288559, AddexBio:C0009005/41, ArrayExpress:E-MEXP-2623, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-5197, ATCC:CCL-247, BCRC:60349, BCRJ:0288, BioGRID_ORCS_Cell_line:97, BioSample:SAMN03470980, BioSample:SAMN03471481, BioSample:SAMN03473487, BioSample:SAMN05292433, BioSample:SAMN10988251, cancercelllines:CVCL_0291, CCRID:1101HUM-PUMC000158, CCRID:1101HUM-PUMC000331, CCRID:3101HUMTCHu99, CCRID:4201HUM-CCTCC00625, Cell_Model_Passport:SIDM00783, ChEMBL-Cells:CHEMBL3308372, ChEMBL-Targets:CHEMBL394, CLS:300195, ColonAtlas:HCT116, Cosmic:711257, Cosmic:720329, Cosmic:724840, Cosmic:869794, Cosmic:870449, Cosmic:873701, Cosmic:875296, Cosmic:875425, Cosmic:875847, Cosmic:876644, Cosmic:876706, Cosmic:887223, Cosmic:889535, Cosmic:897457, Cosmic:902790, Cosmic:905936, Cosmic:913887, Cosmic:934564, Cosmic:947355, Cosmic:948126, Cosmic:948861, Cosmic:985996, Cosmic:995410, Cosmic:1043815, Cosmic:1044257, Cosmic:1045410, Cosmic:1057752, Cosmic:1066205, Cosmic:1067220, Cosmic:1092600, Cosmic:1102383, Cosmic:1122325, Cosmic:1131683, Cosmic:1132568, Cosmic:1132689, Cosmic:1154644, Cosmic:1175840, Cosmic:1176588, Cosmic:1183769, Cosmic:1184080, Cosmic:1184333, Cosmic:1187306, Cosmic:1218874, Cosmic:1223141, Cosmic:1305353, Cosmic:1310945, Cosmic:1332008, Cosmic:1436021, Cosmic:1466804, Cosmic:1466815, Cosmic:1479594, Cosmic:1486132, Cosmic:1519359, Cosmic:1524003, Cosmic:1524333, Cosmic:1552179, Cosmic:1571772, Cosmic:1609495, Cosmic:1672408, Cosmic:1676727, Cosmic:1708402, Cosmic:1805253, Cosmic:1927246, Cosmic:1945865, Cosmic:1995437, Cosmic:1998442, Cosmic:2036656, Cosmic:2046556, Cosmic:2052593, Cosmic:2145576, Cosmic:2301978, Cosmic:2389569, Cosmic:2433755, Cosmic:2464667, Cosmic:2550353, Cosmic:2646766, Cosmic:2651864, Cosmic:2667881, Cosmic:2667972, Cosmic:2668248, Cosmic:2727479, Cosmic:2760068, Cosmic:2787545, Cosmic:2811054, Cosmic-CLP:905936, DepMap:ACH-000971, DSMZ:ACC-581, DSMZCellDive:ACC-581, ECACC:91091005, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, ENCODE:ENCBS004UZY, ENCODE:ENCBS009DQE, ENCODE:ENCBS257IHV, ENCODE:ENCBS378ENC, ENCODE:ENCBS389ENC, ENCODE:ENCBS409ENC, ENCODE:ENCBS409MTT, ENCODE:ENCBS431ENC, ENCODE:ENCBS471AAA, ENCODE:ENCBS472AAA, ENCODE:ENCBS475AAA, ENCODE:ENCBS476AAA, ENCODE:ENCBS494OPB, ENCODE:ENCBS615KTO, ENCODE:ENCBS626JHZ, ENCODE:ENCBS650OZU, ENCODE:ENCBS847SOB, ENCODE:ENCBS851PYB, GDSC:905936, GEO:GSM810, GEO:GSM2143, GEO:GSM50188, GEO:GSM50252, GEO:GSM115118, GEO:GSM206501, GEO:GSM274713, GEO:GSM274714, GEO:GSM274726, GEO:GSM383862, GEO:GSM383867, GEO:GSM383868, GEO:GSM384091, GEO:GSM384092, GEO:GSM481405, GEO:GSM513818, GEO:GSM514292, GEO:GSM580039, GEO:GSM580040, GEO:GSM741266, GEO:GSM743443, GEO:GSM749774, GEO:GSM750773, GEO:GSM750793, GEO:GSM784012, GEO:GSM799331, GEO:GSM799394, GEO:GSM827446, GEO:GSM846355, GEO:GSM887062, GEO:GSM888132, GEO:GSM945287, GEO:GSM945304, GEO:GSM1022651, GEO:GSM1022652, GEO:GSM1153399, GEO:GSM1178133, GEO:GSM1178134, GEO:GSM1178135, GEO:GSM1181250, GEO:GSM1181367, GEO:GSM1346874, GEO:GSM1374516, GEO:GSM1374517, GEO:GSM1374518, GEO:GSM1404391, GEO:GSM1404392, GEO:GSM1448092, GEO:GSM1669868, GEO:GSM2124655, GEO:GSM2550001, GEO:GSM3145712, GEO:GSM3591761, IARC_TP53:21064, ICLC:HTL95025, IZSLER:BS TCL 100, KCB:KCB 200706YJ, KCLB:10247, LiGeA:CCLE_168, LINCS_LDP:LCL-1161, Lonza:691, MeSH:D045325, MetaboLights:MTBLS227, NCBI_Iran:C570, NCI-DTP:HCT-116, PharmacoDB:HCT116_517_2019, PRIDE:PXD000089, PRIDE:PXD000394, PRIDE:PXD001352, PRIDE:PXD001426, PRIDE:PXD001546, PRIDE:PXD001550, PRIDE:PXD002453, PRIDE:PXD002793, PRIDE:PXD004452, PRIDE:PXD005235, PRIDE:PXD005354, PRIDE:PXD005355, PRIDE:PXD005942, PRIDE:PXD005946, PRIDE:PXD025898, PRIDE:PXD030304, PRIDE:PXD032264, PRIDE:PXD037651, Progenetix:CVCL_0291, PubChem_Cell_line:CVCL_0291, RCB:RCB2979, SKY/M-FISH/CGH:1687, SKY/M-FISH/CGH:2778, SKY/M-FISH/CGH:2785, SKY/M-FISH/CGH:3883, TOKU-E:1422, Ubigene:YC-C004, Wikidata:Q28334584 |
|
|
CVCL_0291 |
2025-01-31 12:15:30 |
15362 |
Hep-G2/C3A
Resource Report
Resource Website
100+ mentions
|
(RRID:CVCL_1098)
|
|
|
Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep exome analysis., Virology: Susceptible to infection by Zika virus (ZIKV) (PubMed=29468137)., Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line.
|
PMID:12068308 PMID:20164919 PMID:20215515 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:29468137 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
HepG2/C3A, Hep G2/C3A, C3A |
|
|
BTO:BTO_0003586, CLO:CLO_0002119, EFO:EFO_0002121, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CRL-3581, ATCC:CRL-10741, BCRC:60177, BCRJ:0291, BioSample:SAMN03473207, BioSample:SAMN10987645, cancercelllines:CVCL_1098, Cell_Model_Passport:SIDM01237, ChEMBL-Cells:CHEMBL3308377, ChEMBL-Targets:CHEMBL1075402, Cosmic:724820, Cosmic:910850, Cosmic:1995354, Cosmic-CLP:910850, DepMap:ACH-001021, EGA:EGAS00001000610, EGA:EGAS00001000978, FCS-free:10-2-11-3-4-4, GDSC:910850, GEO:GSM886899, GEO:GSM887964, GEO:GSM1669638, IARC_TP53:21205, IARC_TP53:27688, IGRhCellID:C3A, LINCS_LDP:LCL-1927, PharmacoDB:C3A_156_2019, PRIDE:PXD030304, Progenetix:CVCL_1098, PubChem_Cell_line:CVCL_1098, Ubigene:YC-C093, Wikidata:Q54882789 |
|
|
CVCL_1098 |
2025-01-31 12:16:27 |
119 |
Farage
Resource Report
Resource Website
1+ mentions
|
(CLS Cat# 305071, RRID:CVCL_3302)
|
|
|
Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: Protein expression by reverse-phase protein arrays., Omics: miRNA expression profiling., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep exome analysis., Omics: CNV analysis., Omics: Array-based CGH., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9172815 PMID:11378582 PMID:19278952 PMID:19358282 PMID:20215515 PMID:20628145 PMID:23292937 PMID:25485619 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
FARAGE, Farage OL, Farage Original Line |
CLS |
305071 |
CLO:CLO_0002997, EFO:EFO_0006393, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CRL-2630, BioSample:SAMN03471757, cancercelllines:CVCL_3302, CCRID:4201HUM-CCTCC00319, CCTCC:GDC0319, Cell_Model_Passport:SIDM00859, ChEMBL-Cells:CHEMBL4483171, ChEMBL-Targets:CHEMBL4483236, CLS:305071, Cosmic:1295510, Cosmic:1517602, Cosmic:1541919, Cosmic:1945180, Cosmic:2022591, Cosmic:2276315, Cosmic-CLP:1297449, DepMap:ACH-001498, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1297449, GEO:GSM380125, GEO:GSM552429, GEO:GSM907525, GEO:GSM1035331, GEO:GSM1374481, GEO:GSM1669792, IGRhCellID:Farage, LINCS_LDP:LCL-1131, PharmacoDB:Farage_366_2019, PRIDE:PXD028647, PRIDE:PXD030304, Progenetix:CVCL_3302, PubChem_Cell_line:CVCL_3302, Wikidata:Q54833249 |
|
|
CVCL_3302 |
2025-01-31 12:03:03 |
4 |
Granta-519
Resource Report
Resource Website
1+ mentions
|
(RRID:CVCL_1818)
|
|
|
Omics: Virome analysis using RNAseq., Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: Protein expression by reverse-phase protein arrays., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep exome analysis., Omics: Array-based CGH., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: LL-100 blood cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:7849311 PMID:8036001 PMID:9001420 PMID:12169673 PMID:12683869 PMID:15350304 PMID:16448697 PMID:16960149 PMID:17332242 PMID:20215515 PMID:20454443 PMID:21746927 PMID:22460905 PMID:24362935 PMID:25355872 PMID:25485619 PMID:25688540 PMID:25877200 PMID:25960936 PMID:26194763 PMID:26589293 PMID:27397505 PMID:28196595 PMID:29666304 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:31160637 PMID:35839778
|
Cancer cell line
|
Female |
GRANTA-519, Granta 519, Granta519, GRANTA519, G-519, G519 |
|
|
CLO:CLO_0003561, EFO:EFO_0005369, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-7721, ArrayExpress:E-MTAB-7722, BioSample:SAMN03472258, BioSample:SAMN10988429, cancercelllines:CVCL_1818, Cell_Model_Passport:SIDM01058, ChEMBL-Cells:CHEMBL4483170, ChEMBL-Targets:CHEMBL4483240, Cosmic:1037808, Cosmic:1047113, Cosmic:1291032, Cosmic:1881780, Cosmic:2296989, Cosmic:2756233, Cosmic-CLP:1303897, DepMap:ACH-000073, DSMZ:ACC-342, DSMZCellDive:ACC-342, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:1303897, GEO:GSM95562, GEO:GSM95567, GEO:GSM104459, GEO:GSM115802, GEO:GSM155069, GEO:GSM155070, GEO:GSM155071, GEO:GSM274840, GEO:GSM629484, GEO:GSM629485, GEO:GSM827167, GEO:GSM887028, GEO:GSM888098, GEO:GSM907517, GEO:GSM1266777, GEO:GSM1266778, GEO:GSM1374484, GEO:GSM1669815, GEO:GSM2322618, GEO:GSM3150245, IARC_TP53:25016, LiGeA:CCLE_863, LINCS_LDP:LCL-1126, Lonza:257, PharmacoDB:GRANTA519_414_2019, PRIDE:PXD012087, PRIDE:PXD020750, PRIDE:PXD030304, Progenetix:CVCL_1818, PubChem_Cell_line:CVCL_1818, Wikidata:Q54871671 |
|
|
CVCL_1818 |
2025-01-31 12:12:26 |
4 |
GP5d
Resource Report
Resource Website
1+ mentions
|
(RRID:CVCL_1235)
|
|
|
Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: Protein expression by reverse-phase protein arrays., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep quantitative phosphoproteome analysis., Omics: Deep exome analysis., Omics: CRISPR phenotypic screen., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:7601566 PMID:10051639 PMID:10737795 PMID:20215515 PMID:20570890 PMID:20606684 PMID:24755471 PMID:25485619 PMID:25877200 PMID:25926053 PMID:25944804 PMID:26589293 PMID:27397505 PMID:28196595 PMID:28854368 PMID:29444439 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
Gp5d, Gp5D, GP5D |
|
|
CLO:CLO_0003555, EFO:EFO_0006576, CLDB:cl1512, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:877, BioSample:SAMN03472981, cancercelllines:CVCL_1235, Cell_Model_Passport:SIDM00537, ChEMBL-Cells:CHEMBL3308735, ChEMBL-Targets:CHEMBL1075450, ColonAtlas:GP5d, Cosmic:907291, Cosmic:995384, Cosmic:1043811, Cosmic:1479572, Cosmic:1609497, Cosmic:1803941, Cosmic:2301974, Cosmic:2800587, Cosmic-CLP:907291, DepMap:ACH-001345, ECACC:95090715, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:907291, GEO:GSM827313, GEO:GSM1346871, GEO:GSM1448106, GEO:GSM1669814, IARC_TP53:21348, LINCS_LDP:LCL-1176, PharmacoDB:GP5d_411_2019, PRIDE:PXD005235, PRIDE:PXD030304, Progenetix:CVCL_1235, PubChem_Cell_line:CVCL_1235, Wikidata:Q54871634 |
|
|
CVCL_1235 |
2025-01-31 12:12:25 |
2 |
GR-ST
Resource Report
Resource Website
|
(RRID:CVCL_1236)
|
|
|
Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep exome analysis., Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:7538617 PMID:20164919 PMID:27397505 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
GRST |
|
|
CLO:CLO_0050981, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, BioSample:SAMN03472171, cancercelllines:CVCL_1236, Cell_Model_Passport:SIDM01259, ChEMBL-Cells:CHEMBL3308529, ChEMBL-Targets:CHEMBL2366111, Cosmic:906877, Cosmic-CLP:906877, DepMap:ACH-002238, EGA:EGAS00001000978, GDSC:906877, GEO:GSM1669816, IARC_TP53:21350, LINCS_LDP:LCL-1045, PharmacoDB:GRST_413_2019, PRIDE:PXD030304, PubChem_Cell_line:CVCL_1236, RCB:RCB1182, Wikidata:Q54871662 |
|
|
CVCL_1236 |
2025-01-31 12:12:26 |
0 |
H-EMC-SS
Resource Report
Resource Website
1+ mentions
|
(RCB Cat# RCB0508, RRID:CVCL_1238)
|
|
|
Caution: Does not harbor a gene fusion involving EWSR1 which is a hallmark of extraskeletal myxoid chondrosarcoma (PubMed=34413129)., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep exome analysis., Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:20164919 PMID:20215515 PMID:27397505 PMID:30894373 PMID:34413129 PMID:35839778
|
Cancer cell line
|
Female |
HEMCSS, HEMC-SS |
RCB |
RCB0508 |
CLO:CLO_0003701, CLO:CLO_0051381, CLDB:cl1625, CLDB:cl4965, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, BioSample:SAMD00005690, BioSample:SAMN03472276, cancercelllines:CVCL_1238, Cell_Model_Passport:SIDM00535, ChEMBL-Cells:CHEMBL3308736, ChEMBL-Targets:CHEMBL1075451, Cosmic:907290, Cosmic-CLP:907290, DepMap:ACH-001519, ECACC:94042258, EGA:EGAS00001000978, GDSC:907290, GEO:GSM827448, GEO:GSM1669877, IARC_TP53:21353, ICLC:HTL99016, LINCS_LDP:LCL-1458, PharmacoDB:HEMCSS_419_2019, PRIDE:PXD030304, Progenetix:CVCL_1238, PubChem_Cell_line:CVCL_1238, RCB:RCB0508, Wikidata:Q54871889 |
|
|
CVCL_1238 |
2025-01-31 12:12:36 |
2 |
H4
Resource Report
Resource Website
10+ mentions
|
(RRID:CVCL_1239)
|
|
|
Miscellaneous: Originally classified as originating from a neuroglioma, an obsolete classification. This cell line has been reclassified as an astrocytoma., Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep exome analysis., Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: PTEN genetic alteration cell panel (ATCC TCP-1030)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:4544026 PMID:6256643 PMID:6500159 PMID:10074188 PMID:10560660 PMID:11414198 PMID:11508811 PMID:19435942 PMID:20164919 PMID:20215515 PMID:22460905 PMID:26589293 PMID:27397505 PMID:30894373 PMID:31068700 PMID:31395879 PMID:35839778
|
Cancer cell line
|
Male |
H-4 |
|
|
BTO:BTO_0003704, CLO:CLO_0003599, EFO:EFO_0002184, CLDB:cl5193, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:HTB-148, BCRJ:0263, BioGRID_ORCS_Cell_line:430, BioSample:SAMN03472722, BioSample:SAMN10987915, cancercelllines:CVCL_1239, CCRID:1101HUM-PUMC000372, CCRID:4201HUM-CCTCC00128, CCTCC:GDC0128, Cell_Model_Passport:SIDM00852, ChEMBL-Cells:CHEMBL3308507, ChEMBL-Targets:CHEMBL1075452, CLS:300184, Cosmic:687571, Cosmic:849856, Cosmic:907042, Cosmic:1610749, Cosmic:1746955, Cosmic:2060805, Cosmic:2302320, Cosmic:2367529, Cosmic-CLP:907042, DepMap:ACH-000389, EGA:EGAS00001000978, ENCODE:ENCBS381KGR, ENCODE:ENCBS836LDB, ENCODE:ENCBS902ISQ, GDSC:907042, GEO:GSM326236, GEO:GSM887031, GEO:GSM888101, GEO:GSM1669834, IARC_TP53:21355, IGRhCellID:H4, IZSLER:BS TCL 102, KCB:KCB 2012027YJ, LiGeA:CCLE_383, LINCS_LDP:LCL-1401, Lonza:285, PharmacoDB:H4_437_2019, PRIDE:PXD030304, Progenetix:CVCL_1239, PubChem_Cell_line:CVCL_1239, TOKU-E:1367, Wikidata:Q54872126 |
|
|
CVCL_1239 |
2025-01-31 12:12:45 |
27 |